Entry into a Material Definitive Agreement · Regulation FD Disclosure
Item 1.01. Entry into a Material Definitive Agreement. On December 12, 2025, LightPath Technologies, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC and Craig-Hallum Capital Group LLC, as representatives of the several underwriters named therein (the “Underwriters”), relating to an underwritten public of…
Filed Dec 12, 2025Accepted Dec 12, 2025, 4:44 PM ESTCIK 889971Accession 0001654954-25-013906
LightPath Technologies, Inc. (NASDAQ: LPTH) is a leading provider of next-generation optics and imaging systems for both defense and commercial applications. As a vertically integrated solutions provider with in-house engineering design support, LightPath’s family of custom solutions range from proprietary BlackDiamond™ chalcogenide-based glass materials - sold under exclusive license from the U.S. Naval Research Laboratory - to complete infrared optical systems and thermal imaging assemblies. The Company's primary manufacturing footprint is located in Orlando, Florida with additional facilities in Texas, New Hampshire, Latvia and China. To learn more, please visit www.lightpath.com.
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry into a Material Definitive Agreement.
On December 12, 2025, LightPath Technologies, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Canaccord Genuity LLC and Craig-Hallum Capital Group LLC, as representatives of the several underwriters named therein (the “Underwriters”), relating to an underwritten public offering (the “Offering”) of 7,750,000 shares (the “Firm Shares”) of the Company’s Class A common stock, par value $0.01 per share (the “Class A common stock”), at a public offering price of $7.75 per share. Pursuant to the terms of the Underwriting Agreement, the Company granted to the Underwriters a 30-day option to purchase up to an additional 1,162,500 shares of Class A common stock in the Offering (the “Optional Shares” and together with the Firm Shares, the “Shares”) at the public offering price. The Offering is expected to close on December 15, 2025, subject to customary closing conditions.
The Company estimates that the net proceeds from the Offering will be approximately $56.8 million after deducting underwriting discounts and commissions and other estimated offering expenses to be paid by the Company. The Company intends to use the net proceeds (after the payment of any offering expenses and/or underwriting discounts and commissions) from the sale of the Shares for working capital, investments, acquisitions and general corporate purposes.
The Offering was made pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-291717), filed on November 21, 2025, that was declared effective by the Securities and Exchange Commission on December 10, 2025, and a related prospectus supplement thereunder.
Pursuant to the terms of the Underwriting Agreement, the Company has agreed to certain restrictions on the issuance and sale of its Class A common stock and securities convertible into shares of Class A common stock during the 90-day period following the date of the Underwriting Agreement, subject to specified exceptions.
The Underwriting Agreement contains customary representations and warranties, conditions to closing, termination provisions, and indemnification obligations of the Company, including for liabilities under the Securities Act of 1933, as amended (the “Securities Act”). A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.
Pursuant to the terms of the Underwriting Agreement, the Company has agreed to certain restrictions on the issuance and sale of its Common Stock and securities convertible into shares of Common Stock during the 90-day period following the date of the Underwriting Agreement.
The Underwriting Agreement contains customary representations and warranties, conditions to closing, termination provisions, and indemnification obligations of the Company, including for liabilities under the Securities Act of 1933, as amended. A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference. The foregoing description of the Underwriting Agreement is qualified in its entirety by reference to such exhibit.
The Company is filing the opinion of its counsel, Baker & Hostetler LLP, relating to the legality of the issuance and sale of the Shares, as Exhibit 5.1 hereto, which is incorporated herein by reference.
This Current Report on Form 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On December 11, 2025, the Company issued a press release announcing the launch of the Offering (the “Launch Press Release”), and on December 12, 2025, the Company issued a press release announcing that it had priced the Offering (the “Pricing Press Release”). Copies of the Launch Press Release and Pricing Press Release are furnished hereto as Exhibit 99.1 and Exhibit 99.2, respectively.
The information in this Current Report on Form 8-K under Item 7.01, including the information contained in Exhibit 99.1 and Exhibit 99.2, is being furnished to the SEC and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by a specific reference in such filing.
Filed exhibits (2)
EX-99.1 (by filename) lpth_ex991.htm
EX-99.1
4
lpth_ex991.htm
PRESS RELEASE
lpth_ex991.htm
EXHIBIT 99.1
LightPath Technologies, Inc. Announces Proposed Public Offering of Common Stock
ORLANDO, FL - December 11, 2025 - LightPath Technologies, Inc. (NASDAQ: LPTH) (“LightPath,” the “Company,” “we,” or “our”), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced that it has commenced an underwritten public offering of shares of its Class A common stock. In addition, LightPath expects to grant the underwriters a 30-day option to purchase up to an additional 15% of shares of Class A common stock at the public offering price for the Class A common stock, less underwriting discounts and commissions. All shares of Class A common stock are being offered by LightPath. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the proposed offering.
Canaccord Genuity and Craig-Hallum are acting as joint bookrunners and representatives of the underwriters for the proposed offering.
LightPath intends to use the net proceeds from the…
EX-99.2
5
lpth_ex992.htm
PRESS RELEASE
lpth_ex992.htm
EXHIBIT 99.2
LightPath Technologies, Inc. Announces Pricing of $60 Million Public Offering of Common Stock
ORLANDO, FL - December 12, 2025 - LightPath Technologies, Inc. (NASDAQ: LPTH) (“LightPath,” the “Company,” “we,” or “our”), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced the pricing of an underwritten public offering of 7,750,000 shares of its Class A common stock at a price to the public of $7.75 per share for gross proceeds of approximately $60 million, before deducting underwriting discounts and commissions and other estimated offering expenses. In addition, LightPath has granted the underwriters a 30-day option to purchase up to an additional 1,162,500 shares of its Class A common stock at the public offering price for the Class A common stock, less underwriting discounts and commissions. All shares of Class A common stock are being offered by LightPath. The offering is expected to close on or about December 15, 2025, subject to the satisfaction of customary closing conditions.
Canaccord Genuity and Craig-Hallum are acting as joint …